Astragaloside VI Ameliorates Post-Stroke Depression via Upregulating the NRG-1-Mediated MEK/ERK Pathway

Background: Post-stroke depression (PSD) has been identified as one of the most commonly occurring complications attributed to stroke. Astragaloside VI (AsVI), which is an active Radix Astragali (AR)-derived compound, has been reported to be a potential drug for post-stroke therapy, but its effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Xi, Shen, Jiangang, Zhou, Qing, Jin, Xinchun, Liu, Haosheng, Gao, Ran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784132/
https://www.ncbi.nlm.nih.gov/pubmed/36559001
http://dx.doi.org/10.3390/ph15121551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9784132/
https://www.ncbi.nlm.nih.gov/pubmed/36559001
http://dx.doi.org/10.3390/ph15121551

Ejemplares similares